Track Inspire Medical Systems, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Inspire Medical Systems, Inc. INSP Open Inspire Medical Systems, Inc. in new tab

54.99 USD
P/E
9.99
EPS
4.89
P/B
1.79
ROE
19.77
Beta
0.78
Target Price
79.42 USD
Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc.

🧾 Earnings Recap – Q3 2025

Inspire Medical Systems delivered robust third-quarter results, with revenue rising 10% year-over-year to $224.5 million, supported by strong patient adoption and favorable reimbursement developments.

  • Operating income reached $9.6 million, with earnings per share guidance upgraded to $0.90–$1.00, reflecting improved cost discipline and revenue growth.
  • Physician training for the Inspire V system is over 98% complete, and contracting is over 90% finalized, positioning the company for a successful product launch.
  • Recent clinical studies highlighted Inspire’s effectiveness in reducing long-term cardiovascular risks in OSA patients, reinforcing the company's commitment to innovation and patient outcomes.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 4, 2026
P/E9.99
EPS4.89
Book Value27.33
Price to Book1.79
Debt/Equity4.12
% Insiders1.509%
Growth
Revenue Growth0.12%
Earnings Growth3.08%
Estimates
Forward P/E18.17
Forward EPS2.69
Target Mean Price79.42

DCF Valuation

Tweak assumptions to recompute fair value for Inspire Medical Systems, Inc. (INSP)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Inspire Medical Systems, Inc. Logo Inspire Medical Systems, Inc. Analysis (INSP)

United States Health Care Official Website Stock

Is Inspire Medical Systems, Inc. a good investment? Inspire Medical Systems, Inc. (INSP) is currently trading at 54.99 USD. Market analysts have a consensus price target of 79.42 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 9.99. This relatively low multiple may signal that Inspire Medical Systems, Inc. is undervalued compared to historical market norms.

Earnings Schedule: Inspire Medical Systems, Inc. is expected to release its next earnings report on May 4, 2026. The market consensus estimate for Forward EPS is 2.69.

Investor FAQ

Does Inspire Medical Systems, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Inspire Medical Systems, Inc.?

Inspire Medical Systems, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 4, 2026. The company currently has a trailing EPS of 4.89.

Company Profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Exchange Ticker
NYQ (United States) INSP
Historical Dividends
Year Total Dividends
2008 9.00 USD

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion